Case-Control Study to Investigate the Association Between Serum Apolipoprotein B/A1 Ratio and Atrial Fibrillation by Sex in 920 Patients from China

14 May 2022 : Clinical Research

Xia Zhong^1ACE, Huachen Jiao^2DFG*, Dongsheng Zhao^1BC, Jing Teng^1AF, Mengqi Yang

^1BE

DOI: 10.12659/MSM.936425

Med Sci Monit 2022; 28:e936425

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Differences of serum APOB/APOA1 ratio in male and female patients with atrial fibrillation.

Variable	n	APOB/APOA1 ratio	P value
Paroxysmal AF
Men	174	0.83±0.74	0.099
Women	146	0.73±0.27	0.099
Permanent AF
Men	186	0.73±0.27	0.455
Women	314	0.71±0.30	0.455
AF+hypertension
Men	293	0.77±0.62	0.208
Women	345	0.72±0.30	0.208
AF+CHD
Men	393	0.77±0.54	0.107
Women	419	0.72±0.30	0.107
AF+diabetes
Men	138	0.84±0.83	0.159
Women	136	0.73±0.38	0.159
AF patients using statins
Men	304	0.76±0.59	0.110
Women	301	0.70±0.28	0.110
AF patients non-using statins
Men	156	0.76±0.28	0.368
Women	159	0.73±0.31	0.368
Data are presented as mean±SD. AF – atrial fibrillation; APOA1 – apolipoprotein A1; APOB – apolipoprotein B; CHD – coronary heart disease.

Back to the Article